IL17F and lymphedema: Most effector cytokines known to be produced by Th17 cells—IL-17A, IL-17F, and IL-21 (with the exception of IL-22)—are induced at significantly higher levels in patients with lymphedema, suggesting an important role for these cytokines in development of this disease process.